Cratal for children film-coated tablets 20 pieces

• active ingredients: 1 tablet contains hawthorn fruit extract thick (Crataegiae fructus extractum spissum) ((3.0-3.3):1, extractant: ethanol 70% (v/v)), calculated on dry matter – 21.5 mg; stinging nettle extract thick (Leonuriae herba extractum spissum) ((4.5-5.6):1, extractant: ethanol 70% (v/v)), calculated on dry matter – 43.5 mg; taurine, calculated on 100% dry matter – 433.5 mg;
• excipients: microcrystalline cellulose, croscarmellose sodium, magnesium stearate, colloidal anhydrous silicon dioxide, polyvinyl alcohol, macrogol, talc, titanium dioxide (E 171), red iron oxide (E 172), black iron oxide (E 172), yellow iron oxide (E 172).

Hypersensitivity to the components of the drug.

Bradycardia and hypotension are pronounced.

• children aged 6 to 11 years – 1 tablet 3 times a day;
• children aged 12 to 18 years – 2 tablets 3 times a day.

The drug should be taken orally before meals, with sufficient water.

The course of treatment is 1 month. If necessary, the course of treatment can be repeated. The frequency of repeated courses of treatment is prescribed by the doctor individually for each child.

It is recommended to consult a doctor before starting treatment with Cratal for children.

Do not exceed the recommended doses of the drug.

If the signs of the disease do not disappear or, on the contrary, the state of health worsens, or undesirable phenomena appear, it is necessary to stop taking the drug and consult a doctor regarding further use.

Use during pregnancy or breastfeeding

There is currently no data on the use of the drug during pregnancy or breastfeeding.

Children

There is no information on the use of the drug in children under 6 years of age.

Ability to influence reaction speed when driving vehicles or other mechanisms

Applied to children.

Symptoms: hypersensitivity reactions, allergic reactions, hypotension, bradycardia, dyspeptic reactions, general weakness, feeling of fatigue, dizziness, drowsiness.

Treatment: discontinuation of the drug and symptomatic therapy.

Possible manifestations of hypersensitivity, allergic reactions (hyperemia, rash, itching, edema, urticaria), dyspeptic phenomena, general weakness, increased fatigue, dizziness, drowsiness, arterial hypotension, bradycardia.

If any adverse reactions occur, you should consult a doctor.

Potentiates the antianginal effects of nitrates, β-blockers, calcium antagonists, antihypoxants, neuroprotectors, cardiac glycosides. Reduces signs of digitalis intoxication. The drug should not be used together with class III antiarrhythmics, with cisapride.

Store in the original packaging at a temperature not exceeding 25 ºС.

Keep out of reach of children.

Shelf life 3 years.

Do not use the drug after the expiration date indicated on the package.